Drawing for SPECTRAMEANS

USPTO serial 78139316

SPECTRAMEANS

Reviewed by CopyMark Law Group

Reg. 2972715Status 710
Filing date
Status date
Registration date
Jul 19, 2005
Examiner
PERRY, KIMBERLY B
Law office
TMO LAW OFFICE 112

What this means

Status 710 means the registration was cancelled because a required Section 8 declaration of continued use was not filed within the deadline (including any grace period). The federal registration is no longer active. Evaluate filing a new application if you still use the mark, or petition if cancellation was erroneous. Consult counsel on remaining common-law rights.

Status 710: Status 710 means the registration was cancelled because a required Section 8 declaration of continued use was not filed within the deadline (including any grace period). The federal registration is no longer active.

Need help with SPECTRAMEANS?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Goods and services

ClassDescriptionStatusFirst use
005Dietary and nutritional supplementsSECTION 8 - CANCELLEDMar 31, 2004

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

DateCodeEventWhat it means
Feb 26, 2016CAEXCANCELLED SEC. 8 (10-YR)/EXPIRED SECTION 9—
Sep 17, 2010C15AREGISTERED - SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK.—
Sep 16, 2010APRECASE ASSIGNED TO POST REGISTRATION PARALEGAL—
Sep 13, 2010E815TEAS SECTION 8 & 15 RECEIVED—
Jul 19, 2005R.PRREGISTERED-PRINCIPAL REGISTERYour trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive.
Apr 27, 2005REGVLAW OFFICE REGISTRATION REVIEW COMPLETED—
Apr 27, 2005ALIEASSIGNED TO LIE—
Apr 19, 2005CNPRALLOWED PRINCIPAL REGISTER - SOU ACCEPTED—
Apr 13, 2005SUPCSTATEMENT OF USE PROCESSING COMPLETE—
Mar 25, 2005PETGPETITION TO REVIVE-GRANTED—
Jan 14, 2005PETLCOMMUNICATION RECEIVED FROM PETITIONER—
Jan 14, 2005MAILPAPER RECEIVED—
Jan 4, 2005PINMINCOMPLETE PETITION NOTICE MAILED—
Aug 16, 2004IUAFUSE AMENDMENT FILED—
Aug 16, 2004PETRPETITION TO REVIVE-RECEIVED—
Aug 16, 2004MAILPAPER RECEIVED—
Jun 23, 2004ABN6ABANDONMENT - NO USE STATEMENT FILEDThe intent-to-use application was abandoned because no acceptable Statement of Use (or valid extension) was filed before the Notice of Allowance deadline expired. The application is dead unless revived within a limited window.
Apr 10, 2004EX1GSOU EXTENSION 1 GRANTED—
Mar 16, 2004EXT1SOU EXTENSION 1 FILED—
Sep 16, 2003NOAMNOA MAILED - SOU REQUIRED FROM APPLICANTA Notice of Allowance means your intent-to-use application cleared examination and opposition but is not registered yet. You must file a Statement of Use showing the mark in commerce, or request an extension, before the deadline — usually six months from the notice date.
Jun 24, 2003PUBOPUBLISHED FOR OPPOSITIONYour mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance.
Jun 4, 2003NPUBNOTICE OF PUBLICATION—
Apr 25, 2003CNSAAPPROVED FOR PUB - PRINCIPAL REGISTER—
Mar 7, 2003CRFACORRESPONDENCE RECEIVED IN LAW OFFICE—
Feb 5, 2003CNRTNON-FINAL ACTION MAILEDA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Oct 29, 2002DOCKASSIGNED TO EXAMINER—

Frequently asked questions

Related guidance